The North America in vitro diagnostics (IVD) market is set to grow steadily, reaching an estimated value of USD 75 billion by 2035, with a projected CAGR of 5.4% during the forecast period. This growth is largely fueled by increasing demand for accurate, rapid diagnostic solutions, the expansion of personalized healthcare, and ongoing technological innovations across the US and Canada.
Roots Analysis’ latest study, "North America In Vitro Diagnostics Market," offers an in-depth exploration of how the regional market is evolving. The report tracks historical data, evaluates market performance by country, and provides detailed projections through 2035.
It highlights major market drivers, explores opportunities emerging from healthcare digitization and decentralized testing, and profiles key industry players. The study also examines the competitive landscape, evaluating market shares, technology portfolios, innovation pipelines, and strategic initiatives of leading diagnostic firms.
Additionally, the report looks at mergers, acquisitions, partnerships, and product development strategies that top companies are using to maintain leadership and expand their presence. Combining historical insights, current market trends, and future projections, the study presents a complete view of the regional diagnostics landscape.
Competitive Landscape
Key players operating in the North America IVD market include Abbott, Agilent Technologies, BD, Bio-Rad, Danaher, Exact Sciences, Hologic, Illumina, Labcorp, Quest Diagnostics, QuidelOrtho, and Thermo Fisher Scientific. These companies are driving technological innovation, expanding access to advanced diagnostic tests, and transforming healthcare delivery across North America.
Market Segmentation
The North America IVD market has been segmented across several key parameters to provide a detailed understanding of the industry. Based on test type, the market includes laboratory testing and point-of-care testing.
By product, it covers instruments, reagents, and other diagnostic products. Technologies driving the market include immunoassay, hematology, clinical chemistry, molecular diagnostics, coagulation microbiology, and other technologies.
Application areas include infectious disease, diabetes, oncology, cardiology, nephrology, autoimmune disease, drug testing, and other disease areas. End users primarily include hospitals, laboratories, and other healthcare facilities.
Geographically, the study analyzes the US and Canada separately, providing country-specific insights into healthcare infrastructure, regulatory dynamics, and growth opportunities.
Research Methodology
Our research methodology combines primary and secondary research practices. We sourced data from reliable and validated channels and conducted expert consultations to ensure a comprehensive and accurate analysis.
Through detailed desk research and interviews with clinical diagnostics professionals, healthcare providers, and industry experts, we gathered both quantitative and qualitative insights into market trends and future directions.
By integrating real-world perspectives with robust data modeling, our study delivers actionable intelligence to help businesses, policymakers, and healthcare stakeholders navigate the evolving North America IVD market.
We appreciate your interest in our research. For more information or to request a customized version, please get in touch. We are committed to delivering insights designed to meet your strategic needs.
